Topline Capital Management’s Mesa Laboratories MLAB Stock Holding History

Topline Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Buy	+2,374	New	+$239K	0.06%	33

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Topline Capital Management's MLAB Position: Q2 2026 in Review

Topline Capital Management opened a new position in Mesa Laboratories (MLAB) in Q2 2026: 2,374 shares worth $236K. The stake represents 0.06% of the portfolio and ranks #33 among its holdings.

159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Topline Capital Management held 2,374 shares of Mesa Laboratories worth $236K as of Q2 2026.
Mesa Laboratories was a new Topline Capital Management position in Q2 2026.
Mesa Laboratories made up 0.06% of Topline Capital Management's portfolio in Q2 2026, its #33 holding.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Topline Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.